Abstract
By studying tidal volume dependence of diagnostic multiple breath washout (MBW) indices, it can be determined how breathing patterns can be modulated to obtain less variable MBW outcomes and shorten MBW test duration in the clinical routine https://bit.ly/32GxRWj
To the Editor:
Multiple breath washout (MBW) tests have gained interest for clinical use, with normal values being published for the lung clearance index (LCI) in the paediatric [1, 2] and adult range [3, 4]. In adults, the greater interest in mechanisms of acinar and conductive ventilation heterogeneity (reflected in Sacin and Scond, respectively) drove the adoption of a 1 L breathing protocol to ensure a clear estimate of phase III slope. Alternatively, natural breathing protocols aimed to enhance feasibility in paediatric settings [5] have also been used in some adult studies [6]. Since Sacin or Scond are indirect measures of lung structure and its potential abnormality in disease [7, 8], the manoeuvre (natural breathing or not) by which these indices are obtained does not directly alter the underlying process, but merely affects the magnitude of its estimates. In specific age groups, or in patient groups of any age with severe lung disease, a 1 L tidal volume (VT) may not be achievable or may result in an altered functional residual capacity (FRC). VT increases from 0.5 to 1.3 L have led to FRC decrease by 17% in children [9] and by 7% in adults [10]; corresponding LCI increases were observed in children, but not in adults. In natural breathing studies, Sacin and Scond are usually compensated by VT multiplication to account for differences in lung size (multiplication by FRC) and in breathing pattern (multiplication by VT/FRC) [5]. In the present work we systematically studied the effect of natural tidal breathing (MBWnat), 1 L breathing (MBW1L) and 1.5 L breathing (MBW1.5L) on MBW indices LCI, Sacin, Scond and the VT compensation of the latter two, with an aim to distil a breathing modality that may enhance clinical utility of MBW in the future.
40 healthy young adults (20 males, 20 females) were recruited (local ethics committee BUN143201836071) and all nitrogen MBW testing was performed as previously described [11]. Subjects performed nine MBW tests (three sets of three trials, always performing the first set during natural tidal breathing, to avoid a potential impact on this from any larger VT breathing before it). Friedman test and multiple regression were performed using MedCalc (version16.4.3, Mariakerke, Belgium).
In the study cohort (mean±sd age 24.4±3.4 years), mean±sd z-scores for FRC, LCI, Sacin and Scond obtained with the MBW1L test were 0.1±0.8, −0.1±1.1, −0.1±0.8 and −0.1±1.7, respectively, using equipment-specific reference equations [11]; Global Lung Function Initiative-based z-score for forced expiratory volume in 1 s was 0.3±0.09 [12]. Mean±sd trial durations were 191±41 s for MBWnat, 124±26 s for MBW1L and 98±21 s for MBW1.5L. Figure 1 illustrates the effects of VT on raw value FRC, LCI, Sacin and Scond. Compared to MBW1L, natural tidal breathing induced statistically significant but small LCI increases, and a considerable Sacin increase, on average from 0.070 L−1 (MBW1L) to 0.255 L−1 (MBWnat). When VT-compensated as per guidelines [5], a significant difference persisted but mean Sacin·VT increased relatively less, from 0.077 (MBW1L) to 0.150 (MBWnat). While Scond did not show a significant difference (MBW1L 0.030 L−1 versus MBWnat 0.029 L−1), it reached significance for Scond·VT (MBW1L 0.033 versus MBWnat 0.017), suggesting overcompensation by VT. Interestingly, VT compensation works better between MBW1L and MBW1.5L, where VT multiplication better neutralises the consistent Sacin and Scond decreases observed with increased VT (mean Sacin·VT 0.069 for MBW1.5L versus 0.077 for MBW1L, and Scond·VT 0.036 for MBW1.5L versus 0.033 for MBW1L).
Multiple breath washout (MBW)-derived indices as a function of tidal volume (VT) for male (circles) and female (triangles) normal subjects. Closed symbols are mean±sd and positioned at mean VT values corresponding to target volumes of respectively MBWnat, MBW1L and MBW1.5L. Open symbols are individual data points versus individual VT values, connecting MBWnat, MBW1L and MBW1.5L data sets for any given subject (dotted lines). a) Functional residual capacity (FRC); b) lung clearance index (LCI); c) acinar ventilation heterogeneity (Sacin); d) conductive ventilation heterogeneity (Scond).
To investigate whether the experimentally observed degree of VT dependence of Sacin could be replicated based on the underlying model of diffusion–convection interaction, simulations were performed with an adult lung model recently used for simulation of Sacin increases typically seen in COPD [7]. With the model in its normal baseline state (and simulated FRC of 3000 mL), this obtained simulated Sacin values of 0.134 L−1 (750 mL), 0.085 L−1 (1000 mL), 0.060 L−1 (1500 mL); with VT compensation, corresponding simulated Sacin·VT values were 0.101, 0.085 and 0.090.
A striking VT effect in figure 1 is its impact on inter-subject variability. While inter-subject coefficient of variation for this young adult cohort was similar across the studied VT range for FRC (MBWnat 23%; MBW1L 25%; MBW1.5L 25%) and LCI (MBWnat 5.8%; MBW1L 4.8%; MBW1.5L 4.9%), this was not the case for Scond (MBWnat 147%; MBW1L 37%; MBW1.5L 32%) nor for Sacin (MBWnat 59%; MBW1L 30%; MBW1.5L 36%). Also with VT compensation, inter-subject Sacin·VT and Scond·VT variability for MBWnat were 58% and 128%, respectively, and only in the case of Sacin·VT could this be partly accounted for by inter-subject variability in VT and FRC (R2adjusted=0.38; VT: rpartial=−0.35, p=0.03; FRC: rpartial=0.64, p<0.001). What is also apparent from figure 1, is that for any individual with a given FRC, there is a steep dependence of Sacin on VT near natural breathing, such that small variations in VT can result in large Sacin variations. Hence, if subjects are allowed to freely use their natural breathing, instead of a weight- or height-based fixed tidal VT, this will be detrimental to variability of study outcomes. Also, if a treatment were to increase natural VT, a Sacin decrease could signal a treatment effect or a purely volumetric effect, or both.
We show here quantitatively, a VT effect that has long been known to affect ventilation distribution, with increasing VT generally decreasing phase III slopes [13, 14]. The VT compensation is similar to what is done when comparing species, e.g. phase III slopes from humans (in L−1) and rats (in mL−1) [15], where both VT and FRC are scaled by a factor 1000. The present experimental data show that the VT compensation did attenuate dependency of both Sacin and Scond on VT in the 1.0−1.5 L VT range, but that it could not fully compensate Sacin, and even overcompensated Scond in the case of MBWnat. In the case of Sacin, this was supported by model simulations where the purely volumetric effect on diffusion–convection interaction in the lung periphery could be assessed. By contrast, Scond and the conductive ventilation heterogeneity portion of LCI, cannot be readily simulated unless complex patient-specific models are constructed [8].
Besides the increase of Sacin with natural tidal breathing, its variability also increases considerably. Whilst the limits of normal for healthy reference data will take care of this inherent variability, it is tempting to suggest that encouragement to achieve slightly deeper breaths than their natural breathing may benefit MBW measurement variability. Sacin values would indeed become smaller with greater VT, but the VT compensation would work better as one moves away from natural tidal VT, as is seen here in the higher VT range. The recent consensus statement suggested that when assessing Sacin and Scond, “an initial VT range of 10–15 mL·kg−1 can be used but may need to be adjusted for the individual patient depending on the expirogram seen” (table 5 in [5]). Our study, where VT was 9±2 mL·kg−1 for MBWnat and 16±3 mL·kg−1 for MBW1L, shows the benefit of the larger VT in reducing Sacin and Scond variability. Of note, the estimated population-based VT ranges encountered in recent normative studies were ∼13 mL·kg−1 in children [1] and ∼14 mL·kg−1 in adults [4], suggesting that this phenomenon may be less problematic in that paediatric age range (6–18 years) and in existing adult data. As an additional benefit, our data show that the larger VT reduces MBW test duration, i.e. time to achieve the end-of-test concentration threshold for LCI computation.
In conclusion, the quality control required for MBW indices is more complicated than for conventional lung function tests, partly because of VT effects, which may be amplified during natural breathing. In interventional studies, alterations in breathing pattern should be scrutinised when interpreting reported changes in Sacin and Scond, and identifying actual treatment effects. Adoption of procotols with a fixed VT (or higher VT range) rather than natural breathing in study populations where this is feasible, would be expected to decrease Sacin and Scond variability, improve accuracy of any VT compensation applied, and also shorten MBW test duration. LCI variability is less affected by VT and is the more robust index, suggesting it may be more suitable across widely varying patient populations. Future research, within other age ranges and also in the setting of severe lung disease, are needed to examine the generalisability of these findings.
Shareable PDF
Supplementary Material
This one-page PDF can be shared freely online.
Shareable PDF ERJ-02765-2020.Shareable
Footnotes
Author contributions: S. Verbanck conceived of the study, analysed the data and co-wrote the manuscript. D. Schuermans performed the experiments. M. Paiva, P.D. Robinson and E. Vanderhelst provided a scientific critique of the data and co-wrote the manuscript.
Conflict of interest: D. Schuermans has nothing to disclose.
Conflict of interest: M. Paiva has nothing to disclose.
Conflict of interest: P.D. Robinson has nothing to disclose.
Conflict of interest: E. Vanderhelst has nothing to disclose.
Conflict of interest: S. Verbanck has nothing to disclose.
Support statement: This project was supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium).
- Received July 13, 2020.
- Accepted September 14, 2020.
- Copyright ©ERS 2021